Article
The Efficacy of First-Generation EGFR-TKI Combined With Brain Radiotherapy as the First-Line Treatment for Lung Adenocarcinoma Patients With Brain Metastases and EGFR Sensitive Mutations: A Retrospective study.
Technology in cancer research & treatment - 1 Jan 2000
Liu Yuting, Wang Juanjuan, Wu Jingjing, Yang Qifan, Zeng Yulan, Wu Di, Tian Chen, Hu Yue, Gu Feifei, Li Chang, Zhang Kai, Liu Li
Abstract excerpt
BACKGROUND: It was controversial that whether LUAD patients with brain metastases (BMs) and EGFR sensitive mutations should be conducted using brain radiotherapy when treated with first-generation EGFR-TKI. Herein, a retrospective study was designed to compare the efficacy of first-generation EGFR-TKI combined with brain radiotherapy and EGFR-TKI alone as first-line treatment for these LUAD patients. PATIENTS AND...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.